Suppr超能文献

p16、细胞周期蛋白D1、视网膜母细胞瘤蛋白(Rb)及MIB-1水平在颅底脊索瘤和软骨肉瘤中的临床病理意义

Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma.

作者信息

Liu Jun-Qi, Zhang Qiu-Hang, Wang Zhen-Lin

机构信息

Xuanwu Hospital Capital Medical University, China.

出版信息

World J Otorhinolaryngol Head Neck Surg. 2015 Oct 24;1(1):50-56. doi: 10.1016/j.wjorl.2015.09.005. eCollection 2015 Sep.

Abstract

OBJECTIVE

To investigate the expression of p16, cyclin D1, retinoblastoma tumor suppressor protein (Rb) and MIB-1 in skull base chordoma and chondrosarcoma tissues, and to determine the clinicopathological significance of the above indexes in these diseases.

METHODS

A total of 100 skull base chordoma, 30 chondrosarcoma, and 20 normal cartilage tissue samples were analyzed by immunohistochemistry. The expression levels of p16, cyclinD1, Rb and MIB-1 proteins were assessed for potential correlation with the clinicopathological features.

RESULTS

As compared to normal cartilage specimen (control), there was decreased expression of p16, and increased expression of cyclin D1, Rb and MIB-1 proteins, in both skull base chordoma and chondrosarcoma specimens. MIB-1 LI levels were significantly increased in skull base chordoma specimens with negative expression of p16, and positive expression of cyclin D1 and Rb ( < 0.05). Significantly elevated MIB-1 LI was also detected in skull base chondrosarcoma tissues, while there was negative expression of p16, cyclin D1 and Rb ( < 0.05). In skull base chordoma, p16 negatively correlated with cyclin D1 and Rb, while cyclin D1 positively correlated with Rb. Additionally, p16, cyclin D1, Rb, or MIB-1 expression showed no correlation with age, gender, or pathological classification of patients with skull base chordoma ( > 0.05). However, p16 and MIB-1 levels correlated with the intradural invasion, and expression of p16, Rb and MIB-1 correlated with the number of tumor foci ( < 0.05). Further, the expression of p16 and MIB-1 appeared to correlate with the prognosis of patients with skull base chordoma.

CONCLUSIONS

The abnormal expression of p16, cyclin D1 and Rb proteins might be associated with the tumorigenesis of skull base chordoma and chondrosarcoma.

摘要

目的

研究p16、细胞周期蛋白D1、视网膜母细胞瘤肿瘤抑制蛋白(Rb)和MIB-1在颅底脊索瘤和软骨肉瘤组织中的表达情况,并确定上述指标在这些疾病中的临床病理意义。

方法

采用免疫组织化学方法分析100例颅底脊索瘤、30例软骨肉瘤及20例正常软骨组织样本。评估p16、细胞周期蛋白D1、Rb和MIB-1蛋白的表达水平与临床病理特征之间的潜在相关性。

结果

与正常软骨标本(对照)相比,颅底脊索瘤和软骨肉瘤标本中p16表达降低,细胞周期蛋白D1、Rb和MIB-1蛋白表达增加。在p16阴性、细胞周期蛋白D1和Rb阳性表达的颅底脊索瘤标本中,MIB-1 LI水平显著升高(P<0.05)。在p16、细胞周期蛋白D1和Rb均阴性表达的颅底软骨肉瘤组织中也检测到MIB-1 LI显著升高(P<0.05)。在颅底脊索瘤中,p16与细胞周期蛋白D1和Rb呈负相关,而细胞周期蛋白D1与Rb呈正相关。此外,p16、细胞周期蛋白D1、Rb或MIB-1的表达与颅底脊索瘤患者的年龄、性别或病理分类无关(P>0.05)。然而,p16和MIB-1水平与硬膜内侵犯相关,p16、Rb和MIB-1的表达与肿瘤灶数量相关(P<0.05)。此外,p16和MIB-1的表达似乎与颅底脊索瘤患者的预后相关。

结论

p16、细胞周期蛋白D1和Rb蛋白的异常表达可能与颅底脊索瘤和软骨肉瘤的发生有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac92/5698503/9b085e8f33c6/gr1.jpg

相似文献

1
Clinicopathological significance of p16, cyclin D1, Rb and MIB-1 levels in skull base chordoma and chondrosarcoma.
World J Otorhinolaryngol Head Neck Surg. 2015 Oct 24;1(1):50-56. doi: 10.1016/j.wjorl.2015.09.005. eCollection 2015 Sep.
3
Alterations of G1-S checkpoint in chordoma: the prognostic impact of p53 overexpression.
Cancer. 2005 Sep 15;104(6):1255-63. doi: 10.1002/cncr.21296.
4
[The expression of Rb, p16 and cyclin D1 in 41 esophageal cancers].
Zhonghua Bing Li Xue Za Zhi. 1996 Dec;25(6):336-9.
5
Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
J Pathol. 1999 Aug;188(4):351-60. doi: 10.1002/(SICI)1096-9896(199908)188:4<351::AID-PATH385>3.0.CO;2-W.
6
Loss of heterozygosity in the retinoblastoma tumor suppressor gene in skull base chordomas and chondrosarcomas.
Surg Neurol. 1997 Feb;47(2):156-60; discussion 160-1. doi: 10.1016/s0090-3019(96)00432-6.
8
Prognostic role of Rb, p16, Cyclin D1 proteins in soft tissue sarcomas.
Cancer Res Treat. 2010 Sep;42(3):144-50. doi: 10.4143/crt.2010.42.3.144. Epub 2010 Sep 30.

引用本文的文献

1
Latest Developments in Targeted Biological Therapies in the Management of Chordoma and Chondrosarcoma.
Global Spine J. 2025 Jan;15(1_suppl):120S-131S. doi: 10.1177/21925682241227917.
2
Low expression of H3K27me3 is associated with poor prognosis in conventional chordoma.
Front Oncol. 2022 Dec 19;12:1048482. doi: 10.3389/fonc.2022.1048482. eCollection 2022.
3
A correlation analysis of sacrococcygeal chordoma imaging and clinical characteristics with the prognostic factors.
Front Oncol. 2022 Sep 26;12:1012918. doi: 10.3389/fonc.2022.1012918. eCollection 2022.
4
Multivariate Analysis and Validation of the Prognostic Factors for Skull Base Chordoma.
Front Surg. 2021 Nov 23;8:764329. doi: 10.3389/fsurg.2021.764329. eCollection 2021.
5
Targeted Therapy for Chordoma: Key Molecular Signaling Pathways and the Role of Multimodal Therapy.
Target Oncol. 2021 May;16(3):325-337. doi: 10.1007/s11523-021-00814-5. Epub 2021 Apr 24.
6
Correlation of p16 and cyclin D1 expression with the incidence and prognosis of cardiac carcinoma.
Oncol Lett. 2019 Jun;17(6):4859-4864. doi: 10.3892/ol.2019.10189. Epub 2019 Mar 26.

本文引用的文献

2
Molecular Pathways: Targeting the Cyclin D-CDK4/6 Axis for Cancer Treatment.
Clin Cancer Res. 2015 Jul 1;21(13):2905-10. doi: 10.1158/1078-0432.CCR-14-0816. Epub 2015 May 4.
3
Therapeutic targeting of replicative immortality.
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S104-S128. doi: 10.1016/j.semcancer.2015.03.007. Epub 2015 Apr 11.
4
Chordoma and chondrosarcoma.
Otolaryngol Clin North Am. 2015 Jun;48(3):501-14. doi: 10.1016/j.otc.2015.02.009. Epub 2015 Apr 9.
5
Chimeras of p14ARF and p16: functional hybrids with the ability to arrest growth.
PLoS One. 2014 Feb 5;9(2):e88219. doi: 10.1371/journal.pone.0088219. eCollection 2014.
6
Skull base chordomas: clinical features, prognostic factors, and therapeutics.
Neurosurg Clin N Am. 2013 Jan;24(1):79-88. doi: 10.1016/j.nec.2012.08.007. Epub 2012 Oct 10.
9
Molecular pathology and its diagnostic use in bone tumors.
Cancer Genet. 2012 May;205(5):193-204. doi: 10.1016/j.cancergen.2012.04.001.
10
Current therapeutic options and novel molecular markers in skull base chordomas.
Neurosurg Rev. 2012 Jan;35(1):1-13; discussion 13-4. doi: 10.1007/s10143-011-0354-1. Epub 2011 Oct 18.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验